Potentia Pharmaceuticals Appoints Johanna M. Seddon, M.D. and Janet Stoltz Sunness, M.D. to Scientific Advisory Board.
LOUISVILLE, Ky., Nov. 11 /PRNewswire/ -- Potentia Pharmaceuticals, a privately held biotechnology company developing medicines for the treatment of age-related macular degeneration (AMD), announced today the appointments of Johanna M. Seddon, M.D. and Janet Stoltz Sunness, M.D. to its Scientific Advisory Board effective November 6, 2008. Dr....

Ongoing drug safety investigations posted online.
The Food and Drug Administration has posted on its Web site the first quarterly report of drugs identified as having "potential safety issues" that are under evaluation, to keep health care professionals and the public informed about latest drug safety information available, according to the agency. A...

MultiVu Video Feed: New Rapid Test to Diagnose Flu May Help With Upcoming Flu Season.
3M(TM) Rapid Detection Flu A+B Test Differentiates Flu Strains A & B In 15 Minutes Each year up to 20 percent of the U.S. population becomes ill with "the flu." Misdiagnosis of the flu is common as some bacterial infections present similarly to influenza. Because of this,...

Calendar.
Upcoming NEHA conferences June 21-24, 2009: Atlanta, Georgia. June 5-9, 2010: Albuquerque, New Mexico NEHA Affiliate and Regional Listings California April 13-17, 2009: "58th Annual Educational Symposium," sponsored by CEHA, Hyatt Regency, Monterey, CA. For information, contact CEHA Support...

RVX-208 Exploratory Study Illustrates Early Potential for Alzheimer's Disease.
First in class drug illustrates early signal of transport of key amyloid marker from brain TSX Exchange Symbol: RVX CALGARY, Nov. 10 /PRNewswire-FirstCall/ -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) announced today that treatment with its lead drug RVX-208, a first in class ApoA-I/Prebeta-HDL elevating drug, in...

Greater loss of bone density seen in men with diabetes.
MONTREAL -- Loss of bone mineral density over time appears to be more severe in older men with type 2 diabetes than in older men without diabetes, even though men with diabetes have higher average bone mineral density at baseline. Data from 4 years of follow-up from...

Guidelines offer methods for tackling problem of U.S. drugged driving.
NEW guidelines for research on drugged driving aim to help the public health and safety community address a serious problem on U.S. roads. Published in the August issue of the journal Addiction, researchers said a "major problem in assessing the true public health impact of drug use...

FDA releases list of drugs under safety investigation.
The Food and Drug Administration has posted on its Web site the first quarterly report of drugs identified as having "potential safety issues" that are under evaluation, in order to keep health care professionals and the public informed about the latest drug safety information available, the agency announced. ...

NxStage Applauds Array of Studies To Be Presented at American Society of Nephrology Meeting.
Daily Home Hemodialysis and Renal Replacement Therapy in Critical Care Receive Significant Attention LAWRENCE, Mass., Nov. 5 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. , a leading manufacturer of innovative dialysis products, today announced that the annual scientific meeting of the American Society of Nephrology (ASN) will feature multiple...

Diabetic retinopathy improved with candesartan.
ROME -- Candesartan helped prevent the development of new retinopathy in patients with type 1 diabetes, and prevented worsening eye disease in patients with type 1 and type 2 diabetes, data from international studies showed. This was true even though the primary end points of the individual studies were...